Literature DB >> 10828487

Advances in understanding neuronal somatostatin receptors.

I Selmer1, M Schindler, J P Allen, P P Humphrey, P C Emson.   

Abstract

It has long been considered that somatostatin acts as a neuromodulator in the mammalian central nervous system but its precise physiological roles remain elusive. Early studies to identify somatostatin-binding sites revealed a widespread heterogeneous pattern, especially in the CNS. More recently, a family of somatostatin receptors have been identified, of which five genes (sst(1-5)) have been cloned. In this review, we discuss current data describing the localisation of the five receptor types. Recent progress in understanding their function has been made using high-affinity, selective receptor ligands and transgenic animal technology. Finally, the therapeutic potential for somatostatin receptor-selective compounds as analgesics is considered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828487     DOI: 10.1016/s0167-0115(00)00108-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  14 in total

1.  Tonic control of peripheral cutaneous nociceptors by somatostatin receptors.

Authors:  S M Carlton; J Du; S Zhou; R E Coggeshall
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Discovery and Pharmacology of a Novel Somatostatin Subtype 5 (SSTR5) Antagonist: Synergy with DPP-4 Inhibition.

Authors:  Weiguo Liu; Pengcheng P Shao; Gui-Bai Liang; John Bawiec; Jiafang He; Susan D Aster; Margaret Wu; Garry Chicchi; John Wang; Kwei-Lan Tsao; Jin Shang; Gino Salituro; Yun-Ping Zhou; Cai Li; Taro E Akiyama; Daniel E Metzger; Beth Ann Murphy; Andrew D Howard; Ann E Weber; Joseph L Duffy
Journal:  ACS Med Chem Lett       Date:  2018-09-12       Impact factor: 4.345

Review 3.  A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders.

Authors:  Stacey L Robinson; Todd E Thiele
Journal:  Neuropharmacology       Date:  2020-02-03       Impact factor: 5.250

4.  Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective Antagonists.

Authors:  Weiguo Liu; Zahid Hussain; Yi Zang; Ramzi F Sweis; F Anthony Romero; Paul E Finke; Remond Moningka; Jianming Bao; Michael A Plotkin; Jin Shang; Karen H Dingley; Gino Salituro; Beth Ann Murphy; Andrew D Howard; Feroze Ujjainwalla; Harold B Wood; Joseph L Duffy
Journal:  ACS Med Chem Lett       Date:  2018-10-05       Impact factor: 4.345

5.  Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions.

Authors:  Michelle Yeung; Elif Engin; Dallas Treit
Journal:  Psychopharmacology (Berl)       Date:  2011-03-19       Impact factor: 4.530

6.  Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors.

Authors:  Elif Engin; Dallas Treit
Journal:  Psychopharmacology (Berl)       Date:  2009-07-17       Impact factor: 4.530

7.  The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.

Authors:  Lauriaselle Afanador; Ina Mexhitaj; Carolyn Diaz; Dalila Ordonez; Lisa Baker; Jesus A Angulo
Journal:  Brain Res       Date:  2013-03-19       Impact factor: 3.252

8.  Prostaglandin E2 increases the expression of the neurokinin1 receptor in adult sensory neurones in culture: a novel role of prostaglandins.

Authors:  Gisela Segond von Banchet; Anita Scholze; Hans-Georg Schaible
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

9.  Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro.

Authors:  Mark Connor; Elena E Bagley; Vanessa A Mitchell; Susan L Ingram; MacDonald J Christie; Patrick P A Humphrey; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

10.  Somatostatin inhibits tooth-pulp-evoked rat cervical dorsal horn neuronal activity.

Authors:  M Takahashi; M Takeda; S Matsumoto
Journal:  Exp Brain Res       Date:  2008-01-09       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.